Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AvailOm
- Development stage
- Unknown
- Lead developer
- Evonik
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AvailOm is an oral nutraceutical omega-3 lysine complex developed by Evonik that combines the omega-3 free fatty acids eicosapentaenoic acid and docosahexaenoic acid with L-lysine in a solid powder formulation. The complex is designed to dissociate rapidly in the stomach, releasing free fatty acids that can be absorbed without the hydrolysis step required for ethyl ester omega-3 products, which is intended to improve bioavailability. Reported biology includes cardiovascular support effects associated with omega-3 fatty acid delivery and AMPK-eNOS-mediated vasorelaxation signaling, with use positioned for heart, brain, joint, eye, and cerebrovascular health as a dietary supplement ingredient rather than a regulated pharmaceutical drug.
- Brand names
- AvailOm
- Other names
- omega-3 lysine complexomega3 lysine complexomega 3 lysine complexomega-3 free fatty acid lysine complexomega3 free fatty acid lysine complexomega 3 free fatty acid lysine complex
02
Targets
NOS3 (eNOS)AMPK (Adenosine monophosphate–activated protein kinase)
Beyond the preview
Go deeper on AvailOm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AvailOm.